1. Wang, Zhiqiang, Lu, Zhou, Lin, Shengli, Liu, Ronghua, Chu, Yiwei. 2022. Leucine-tRNA-synthase-2-expressing B cells contribute to colorectal cancer immunoevasion. In Immunity, 55, 1067-1081.e8. doi:10.1016/j.immuni.2022.04.017. https://pubmed.ncbi.nlm.nih.gov/35659337/
2. França, Monica Malheiros, Mendonca, Berenice Bilharinho. 2021. Genetics of ovarian insufficiency and defects of folliculogenesis. In Best practice & research. Clinical endocrinology & metabolism, 36, 101594. doi:10.1016/j.beem.2021.101594. https://pubmed.ncbi.nlm.nih.gov/34794894/
3. Carminho-Rodrigues, Maria Teresa, Klee, Phillipe, Laurent, Sacha, Guinand, Nils, Paoloni-Giacobino, Ariane. 2020. LARS2-Perrault syndrome: a new case report and literature review. In BMC medical genetics, 21, 109. doi:10.1186/s12881-020-01028-8. https://pubmed.ncbi.nlm.nih.gov/32423379/
4. 't Hart, Leen M, Hansen, Torben, Rietveld, Ingrid, Heine, Robert J, Maassen, J Antonie. . Evidence that the mitochondrial leucyl tRNA synthetase (LARS2) gene represents a novel type 2 diabetes susceptibility gene. In Diabetes, 54, 1892-5. doi:. https://pubmed.ncbi.nlm.nih.gov/15919814/
5. van der Knaap, Marjo S, Bugiani, Marianna, Mendes, Marisa I, Salomons, Gajja S, Mochel, Fanny. 2019. Biallelic variants in LARS2 and KARS cause deafness and (ovario)leukodystrophy. In Neurology, 92, e1225-e1237. doi:10.1212/WNL.0000000000007098. https://pubmed.ncbi.nlm.nih.gov/30737337/